Suppression of excessive synthesis of CTGF in healthy cells, which is a biomarker for drug-induced gingival overgrowth, may provide a prophylactic benefit in terms of the occurrence of gingival hyperplasia. The gene discussed is CCN2; the disease is gingival disorder.